Madrigal Pharmaceuticals Inc (MDGL)

NASDAQ · Biotechnology

537.70
-2.33 (-0.43%)
Updated Sep 1, 7:56 PM ET
AI Rating
Buy
Overall Score
69
Trend
81
Momentum
73
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Madrigal Pharmaceuticals Inc is trading at $537.70, down 0.43% on the session. The 50 day average sits at $526.52 and the 200 day at $515.09, which puts the stock in a uptrend. RSI is at 53.4, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $526.61 with resistance near $542.78, so that band frames the current range. Average daily movement is roughly $21.34, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 81, momentum of 73 and a risk score of 46.

Technical indicators

RSI (14)
53.4
neutral
MACD
2.311
bullish crossover
SMA 20
519.58
SMA 50
526.52
SMA 200
515.09
uptrend
ATR (14)
21.34
avg daily range
Support
526.61
Resistance
542.78
Volume vs 20d
0.84x
below average
Volatility
43.5%
annualised
1 month
+8.24%
3 months
+7.34%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.